Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.

Sean J JudgeKathleen Lata-AriasMio YanagisawaMorgan A DarrowArta M MonjazebAmanda R KiraneRichard J BoldRobert J CanterDaniel J Canter

Published in: Journal of surgical oncology (2019)

Short-term morbidity and mortality rates after MVR for RPS remain acceptable, but rates of MVR show little change over time in NSQIP hospitals. Concerns about increased morbidity and mortality should not be viewed as a contraindication to wider implementation of MVR for RPS.

Keyphrases

quality improvement
healthcare
acute coronary syndrome
primary care
risk factors
type diabetes
cardiovascular disease
coronary artery disease